StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. Vascular Biogenics has a 1 year low of $0.10 and a 1 year […]
Related Keywords
Israel , United States , , Advisor Group Holdings Inc , Vascular Biogenics Ltd , Renaissance Technologies , Medicard Ltd , Envestnet Asset Management Inc , Vascular Biogenics , Free Report , Get Free Report , Asset Management , Sigma Investments , Advisor Group Holdings , Group Holdings , Biogenics Ltd , Vascular Biogenics Daily , Nasdaq Vblt , Vblt , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.